Sort
261,768 grants matching “gene therapy”
Vision Research Core
$860,918Maureen E Neitz · University Of Washington · P30 · FY2023 · EY
Pediatric Heart Disease: Getting from Mutations to Therapeutics
$860,906Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2018 · HL
Hybrid Antibiotics for Persistent Infections
$860,889Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
Pediatric Heart Disease: Getting from Mutations to Therapeutics
$860,875Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2019 · HL
Pediatric Heart Disease: Getting from Mutations to Therapeutics
$860,844Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2020 · HL
Angiotensin Analogs to Treat Wound Healing
$860,819Kathleen E. Rodgers · Us Biotest, Inc. · R44 · FY2009 · DK
Pediatric Heart Disease: Getting from Mutations to Therapeutics
$860,810Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2021 · HL
Asthma Clinical Research Network (ACRN)
$860,792Wake Forest University Health Sciences · U10 · FY2005 · HL
Pediatric Heart Disease: Getting from Mutations to Therapeutics
$860,775Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2022 · HL
Role of p38 MAPK activation in AIDS pathogenesis
$860,742Anna Aldovini · Boston Children'S Hospital · R01 · FY2016 · AI
Pediatric Heart Disease: Getting from Mutations to Therapeutics
$860,739Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2023 · HL
Role of p38 MAPK activation in AIDS pathogenesis
$860,699Anna Aldovini · Boston Children'S Hospital · R01 · FY2017 · AI
Asthma Clinical Research Network Center at UCSF
$860,696University Of California San Francisco · U10 · FY2005 · HL
Ultrasound-mediated gene delivery to achieve therapeutic correction of hemophilia A
$860,694Carol H Miao · Seattle Children'S Hospital · R01 · FY2020 · HL
Reducing Latent Viral Reservoirs in Infant Macaques
$860,650Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2023 · HD
Accelerating Gene Therapy and Editing with Advanced MS-Based Data Analysis for Nonstandard and Hybrid Nucleotide Sequences
$860,633George Hall Johnson · Massmatrix, Inc. · R44 · FY2023 · GM
Accelerating Gene Therapy and Editing with Advanced MS-Based Data Analysis for Nonstandard and Hybrid Nucleotide Sequences
$860,633George Hall Johnson · Massmatrix, Inc. · R44 · FY2024 · GM
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$860,577Isaac Brownell · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
MGMT OF INFO RESOURCES ON THERAPEUTIC AGENTS FOR HIV AND OPPORTUNISTIC INFECTIONS
$860,506Margaret Rush · Gryphon Scientific, Llc · N01 · FY2011 · AI
Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy
$860,384Siddhesh Angle · Regenosine Inc · R44 · FY2021 · AR
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
$860,375Jason S Debley · Seattle Children'S Hospital · R01 · FY2024 · AI
Cell and Cancer Biology Branch Confocal Microscopy Core
$860,235Yvona Ward · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease
$860,151Kim Tieu · Florida International University · R35 · FY2024 · ES
Development of protein therapeutic for acute kidney injury
$860,143Tao Tan · Trim-Edicine, Inc. · R44 · FY2017 · DK
Animal Models of Diabetic Vascular Disease
$860,134Rockefeller University · U01 · FY2002 · HL